A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules

NCT06224595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: CS32582 capsule
DRUG: Placebo capsule

Sponsor

Chipscreen Biosciences, Ltd.